238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
21.58%
Revenue growth above 20% – Exceptional top-line expansion. Warren Buffett would check if rising costs (e.g., SG&A) are still under control, ensuring profits grow alongside sales.
23.69%
Gross profit growth above 20% – Exceptional. Warren Buffett would verify if increasing margins accompany rising gross profit, not just revenue volume.
7.65%
EBIT growth 5-10% – Moderate. Peter Lynch might look for ways the firm could optimize costs to boost EBIT further.
7.65%
Operating income growth 5-10% – Moderate. Peter Lynch would evaluate product-level profitability to see if certain segments could accelerate growth.
-2.35%
Negative net income growth shows profitability erosion. Benjamin Graham would worry about solvency and longer-term viability.
93.97%
EPS growth above 25% – Exceptional. Warren Buffett would double-check that it’s not solely driven by aggressive buybacks rather than real profit increases.
93.33%
Diluted EPS growth above 25% – Impressive performance. Warren Buffett would confirm if major buybacks or real profit improvements drive these gains.
0.26%
Share count up to +3% – Slight dilution. Howard Marks would be cautious but might accept it if used for profitable growth investments.
-4.77%
Negative growth in diluted shares typically benefits existing owners. Benjamin Graham would check the sustainability of buybacks or reduction in option overhang.
No Data
No Data available this quarter, please select a different quarter.
1.81%
OCF growth 0-5% – Minimal gain. Howard Marks would be cautious about the company’s ability to fund large projects or dividends.
16.48%
FCF growth 15-20% – Strong. Benjamin Graham might verify whether large asset sales or one-time items artificially boosted free cash flow.
773.35%
10Y revenue/share CAGR above 15% – Exceptional long-term expansion. Warren Buffett would confirm if growth is organic, not purely from acquisitions.
773.35%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
773.35%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
607.66%
10Y net income/share CAGR above 15% – Exceptional long-term profit growth. Benjamin Graham would confirm if these gains hold through economic cycles.
607.66%
5Y net income/share CAGR above 15% – Strong mid-term profit growth. Benjamin Graham would check if leverage artificially boosts earnings.
607.66%
3Y net income/share CAGR above 15% – Rapid short-term profit growth. Benjamin Graham would verify if it’s driven by core revenue or temporary cost reductions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.98%
Receivables growth above 20% – Alarm. Philip Fisher demands investigation into possible revenue recognition issues or poor AR management.
No Data
No Data available this quarter, please select a different quarter.
8.68%
Asset growth 5-10% – Reasonable. Peter Lynch compares with revenue growth to ensure utilization remains high.
6.84%
5-8% annual BV/share growth – Decent. Seth Klarman monitors if ROE supports continued expansions.
-100.00%
A negative growth rate in debt means deleveraging, often positive for conservative investors. Benjamin Graham confirms it doesn’t restrict needed investments.
3.53%
R&D growth 0-10% – Balanced approach. Seth Klarman sees manageable cost if new products are still in development.
34.16%
SG&A growth above 15% – Aggressive expense expansion. Philip Fisher demands a compelling ROI argument for such heavy spending.